MedPath
NMPA Product

Radium[223Ra] chloride Injection

Product approved by National Medical Products Administration (CN)

Basic Information

Radium[223Ra] chloride Injection

氯化镭[223Ra]注射液

在基准日期中午12点(欧洲中部时间)时,放射性浓度为1100 kBq/mL(30 μCi/mL),总的放射性活度为6600 kBq/瓶(178 μCi/瓶),每瓶6 mL。

注射剂

Regulatory Information

国药准字HJ20200032

Approved

化学药品

August 26, 2020

Company Information

BAYER AG
Agilera Pharma AS

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath